Zymeworks, Inc. (ZYME)
28.77
+0.10
(+0.35%)
USD |
NASDAQ |
Aug 24, 16:00
29.00
+0.23
(+0.80%)
After-Hours: 20:00
Zymeworks Debt to Equity Ratio : 3.343 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.343 |
| March 31, 2026 | 1.611 |
| December 31, 2025 | 0.068 |
| September 30, 2025 | 0.0591 |
| June 30, 2025 | 0.0558 |
| March 31, 2025 | 0.0568 |
| December 31, 2024 | 0.0546 |
| September 30, 2024 | 0.0552 |
| June 30, 2024 | 0.0494 |
| March 31, 2024 | 0.0576 |
| December 31, 2023 | 0.0575 |
| September 30, 2023 | 0.0621 |
| June 30, 2023 | 0.0607 |
| March 31, 2023 | 0.0577 |
| December 31, 2022 | 0.057 |
| September 30, 2022 | 0.1674 |
| June 30, 2022 | 0.144 |
| March 31, 2022 | 0.1127 |
| December 31, 2021 | 0.1299 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.1082 |
| June 30, 2021 | 0.0991 |
| March 31, 2021 | 0.0223 |
| December 31, 2020 | 0.0211 |
| September 30, 2020 | 0.0185 |
| June 30, 2020 | 0.0175 |
| March 31, 2020 | 0.0174 |
| December 31, 2019 | 0.0282 |
| September 30, 2019 | 0.022 |
| June 30, 2019 | 0.0236 |
| March 31, 2019 | 0.0477 |
| December 31, 2018 | 0.0003 |
| September 30, 2018 | 0.0004 |
| June 30, 2018 | 0.0003 |
| March 31, 2018 | 0.0007 |
| December 31, 2017 | 0.0005 |
| September 30, 2017 | 0.0001 |
| June 30, 2017 | 0.0001 |
| March 31, 2017 | 0.0907 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Theravance Biopharma, Inc. | 0.2463 |
| BridgeBio Pharma, Inc. | -1.353 |
| Aprea Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 396.96M |
| Total Liabilities (Quarterly) | 316.60M |
| Shareholders Equity (Quarterly) | 80.37M |
| Current Ratio | 6.316 |
| Net Debt Paydown Yield | -2.66% |